Detalhe da pesquisa
1.
Association Between Acoustic Features and Neuropsychological Test Performance in the Framingham Heart Study: Observational Study.
J Med Internet Res
; 24(12): e42886, 2022 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36548029
2.
Ledipasvir/Sofosbuvir for 8, 12, or 24 Weeks in Hepatitis C Patients Undergoing Dialysis for End-Stage Renal Disease.
Am J Gastroenterol
; 116(9): 1924-1928, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34465694
3.
Ledipasvir/sofosbuvir with or without ribavirin for 8 or 12 weeks for the treatment of HCV genotype 4 infection: results from a randomised phase III study in Egypt.
Gut
; 68(4): 721-728, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29666174
4.
Sofosbuvir/velpatasvir for 12â¯weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis.
J Hepatol
; 71(4): 660-665, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31195062
5.
Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Genotype 1 Hepatitis C Virus Infection in an Open-Label, Phase 2 Trial.
Gastroenterology
; 151(5): 893-901.e1, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27486034
6.
Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Hepatitis C Virus Genotype 2, 3, 4, or 6 Infections in an Open-Label, Phase 2 Trial.
Gastroenterology
; 151(5): 902-909, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27486033
7.
Efficacy and Safety of Radiotherapy Plus Relugolix in Men With Localized or Advanced Prostate Cancer.
JAMA Oncol
; 10(5): 594-602, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38451492
8.
Bitter taste sensitivity, cruciferous vegetable intake, obesity, and diabetes in American adults: a cross-sectional study of NHANES 2013-2014.
Food Funct
; 14(20): 9243-9252, 2023 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37743833
9.
Establishing cognitive baseline in three generations: Framingham Heart Study.
Alzheimers Dement (Amst)
; 15(1): e12416, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36968621
10.
Impact of Concomitant Cardiovascular Therapies on Efficacy and Safety of Relugolix vs Leuprolide: Subgroup Analysis from HERO Study in Advanced Prostate Cancer.
Adv Ther
; 40(11): 4919-4927, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37713020
11.
Impact of Concomitant Prostate Cancer Medications on Efficacy and Safety of Relugolix Versus Leuprolide in Men With Advanced Prostate Cancer.
Clin Genitourin Cancer
; 21(3): 383-392.e2, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37062659
12.
A Phase I Clinical Trial Evaluating the Safety and Dosing of Relugolix with Novel Hormonal Therapy for the Treatment of Advanced Prostate Cancer.
Target Oncol
; 18(3): 383-390, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37060432
13.
Relugolix vs. Leuprolide Effects on Castration Resistance-Free Survival from the Phase 3 HERO Study in Men with Advanced Prostate Cancer.
Cancers (Basel)
; 15(19)2023 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37835548
14.
Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study.
Eur Urol Oncol
; 2023 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38143206
15.
Proteins as Mediators of the Association Between Diet Quality and Incident Cardiovascular Disease and All-Cause Mortality: The Framingham Heart Study.
J Am Heart Assoc
; 10(18): e021245, 2021 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34482708
16.
A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus.
Nat Med
; 27(12): 2224-2233, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34887572
17.
Sofosbuvir-velpatasvir single-tablet regimen administered for 12 weeks in a phase 3 study with minimal monitoring in India.
Hepatol Int
; 13(2): 173-179, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30790229
18.
Sofosbuvir/velpatasvir for the treatment of HCV: excellent results from a phase-3, open-label study in Russia and Sweden.
Infect Dis (Lond)
; 51(2): 131-139, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30499360
19.
Sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial.
Lancet Gastroenterol Hepatol
; 4(2): 127-134, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30555048
20.
Ledipasvir-Sofosbuvir for 8 Weeks in Non-Cirrhotic Patients with Previously Untreated Genotype 1 HCV Infection ± HIV-1 Co-Infection.
Clin Drug Investig
; 38(3): 239-247, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29177645